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Background
Annotating the genes, transcripts and proteins of the human
genome is a significant challenge. How many genes will
ultimately be identified, what mechanisms control trans-
cription, alternative splicing, the stability of the transcripts,
translatability, what role do non-coding genes play and are
there identifiable signals encoded in the genome sequence
that control these events are all questions that need to be
resolved so that we can hope to annotate the human genome
faithfully. To address this type of question, the ENCODE
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Abstract
Background: Regions covering one percent of the genome, selected by ENCODE for extensive
analysis, were annotated by the HAVANA/Gencode group with high quality transcripts, thus
defining a benchmark. The ENCODE Genome Annotation Assessment Project (EGASP)
competition aimed at reproducing Gencode and finding new genes. The organizers evaluated the
protein predictions in depth. We present a complementary analysis of the mRNAs, including
alternative transcript variants.
Results: We evaluate 25 gene tracks from the University of California Santa Cruz (UCSC)
genome browser. We either distinguish or collapse the alternative splice variants, and compare
the genomic coordinates of exons, introns and nucleotides. Whole mRNA models, seen as chains
of introns, are sorted to find the best matching pairs, and compared so that each mRNA is used
only once. At the mRNA level, AceView is by far the closest to Gencode: the vast majority of
transcripts of the two methods, including alternative variants, are identical. At the protein level,
however, due to a lack of experimental data, our predictions differ: Gencode annotates proteins
in only 41% of the mRNAs whereas AceView does so in virtually all. We describe the driving
principles of AceView, and how, by performing hand-supervised automatic annotation, we solve
the combinatorial splicing problem and summarize all of GenBank, dbEST and RefSeq into a
genome-wide non-redundant but comprehensive cDNA-supported transcriptome. AceView
accuracy is now validated by Gencode.
Conclusions: Relative to a consensus mRNA catalog constructed from all evidence-based
annotations, Gencode and AceView have 81% and 84% sensitivity, and 74% and 73% specificity,
respectively. This close agreement validates a richer view of the human transcriptome, with three
to five times more transcripts than in UCSC Known Genes (sensitivity 28%), RefSeq (sensitivity
21%) or Ensembl (sensitivity 19%).
Open Accessproject [1], launched by the National Human Genome
Research Institute, encourages a concentration of inter-
national efforts and expertise on 1% of the human genome,
in 44 carefully selected regions taken as representative of the
whole genome, in the hope that mature annotation
techniques will be developed, validated, and further applied
to the entire genome.
The UCSC genome browser [2] provides fast and open access
to a highly configurable view of a wealth of sequence-based
genome annotations. The evidence-based or predicted gene
tracks are an open repository for genome-wide annotations
of the genes, and most tracks are well documented. All the
data can easily be retrieved in a uniform format. The
submission process is also simple and friendly, and there are
no signs of limits to the amount of data that can be displayed
and distributed by this group: the UCSC genome browser
was naturally selected as the official repository for sequence-
related data for the ENCODE project [3].
The Human and Vertebrate Analysis and Annotation
(HAVANA) teams are expert at manual gene annotation [4].
They “require that all annotated gene structures (trans-
cripts) are supported by transcriptional evidence, either from
cDNA, expressed sequence tag (EST) or protein sequences,
and as such not all annotated transcripts are necessarily
complete”. They typically bring to the curator, in a
specialized Acedb-based display, a combination of evidence
from alignment of mRNAs, ESTs and proteins, from human
and other vertebrates. Curators hand select the best
supported transcript models, and occasionally experimen-
tally extend or confirm a model, using reverse transcription
polymerase chain reaction and/or rapid amplification of
cDNA ends. In this way, the Sanger Institute group carefully
annotated the 44 ENCODE regions. Their gene models on
these regions are called Gencode. They identify five times
more variants than RefSeq, yet all their transcripts should be
considered experimentally validated.
The ENCODE gene annotation assessment project (EGASP)
[5,6] launched a competition among gene-predicting
programs to try to best reproduce the Gencode annotations,
taken as a reference, and/or to predict novel transcripts; the
most promising novel genes would eventually be validated
by RT-PCR. The Gencode solutions for 13 training regions
were released at the end of 2004, and interested parties were
asked to annotate the remaining 31 test regions before the
solutions were unveiled in May 2005. Sixteen teams
contributed complete mRNA or protein models; AceView
was one of them.
The AceView program [7], developed at NCBI, provides a
strictly cDNA-supported view of the human transcriptome
and the genes by summarizing all quality-filtered human
cDNA data from GenBank, dbEST and the RefSeq. The
nematode version (also known as WormGenes) is even more
evolved and heavily hand curated: it uses over 280,000
cDNA sequencing traces, provided by the Kohara laboratory
(Y Kohara, T Shin-i, Y Suzuki, S Sugano, D Thierry-Mieg and
J Thierry-Mieg, personal communication) and the worm
community, that we hand edit and use as a training set to
handle automatically EST sequence basecall errors. AceView
was written from scratch and guided over the years by visual
expert evaluation and users’ reports; it uses heuristics to
closely reproduce manual curation in an automatic way.
Annotation is a difficult and dynamic problem, and we do
not claim to have a final solution, yet we hope to stimulate
experiments and accelerate discovery. Our results are
frequently updated as new cDNA sequences are submitted to
the nucleotide databases, and they have been publicly
available at NCBI since 2000 [7]. AceView, previously called
Acembly, is also displayed as one of the UCSC gene tracks
and as a DAS track on the Ensembl browser.
We submitted to EGASP a lightly hand edited version of the
public AceView, with the note: “AceView: All mRNAs and
cDNAs available in GenBank, excluding NMs, were co-
aligned on the Gencode regions. The results were then
examined and filtered to resemble HAVANA. The very
restrictive view of HAVANA on CDS was not reproduced,
due to a lack of experimental data.” Our special treatment
consisted of eliminating single exon genes, unless they had a
Pfam annotation (as an unfortunate consequence, we lost a
number of olfactory receptors correctly represented in the
standard AceView) and discarding the RefSeqs, to avoid
second-hand annotation. We also removed several recent
retroposon-type pseudogenes that had escaped our standard
filters and about 50 cDNA clones aligning with non-standard
introns (not GT/AG or GC/AG). Then, after the workshop,
we modified our program to automatically perform some of
this extra filtering: the current genome-wide public
AceView, dated August 2005, benefits from these Gencode-
driven improvements and rates even slightly better than the
EGASP version. Numbers quoted in the text correspond to
the genome-wide version, because it is more relevant to the
AceView users, but the closely similar AceView/EGASP
performances are displayed graphically and in numbers in
Additional data files 2-4.
In the main EGASP paper, Guigo et al. [6] thoroughly
analyze the novel gene predictions and all regions annotated
as protein coding by Gencode; they also present some basic
comparisons of the mRNAs. Their preferred mode is to
project on the genome the features to be compared, for
instance nucleotides or exons, and to count each element
only once per gene, in a way flattening the alternative trans-
cript variants. However, as Gencode indicates, human gene
transcription and splicing patterns are complex, yet not
combinatorial, and the exon-intron chaining cannot be
rendered in projection. We therefore undertook a comple-
mentary analysis of the same data, but focused on the com-
plete mRNAs, irrespective of whether or not they have an
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in comparing the alternative variants across the tracks, using
the complete chains of introns as signatures. We wrote a
standalone program, UCSCtrackCompare, to compare the
models of the various tracks to the Gencode validated
transcripts (October 2005 freeze).
In general agreement with Table 6 from [6] for the projected
view, but much more clearly when we look separately at the
alternative variants, we show that at the mRNA level,
AceView transcripts are by far the closest match to Gencode
transcripts: all nucleotides used in spliced variants are
common, except for 8% specific to Gencode or 12% specific
to AceView. All introns are common, except for 10% specific
to Gencode or 14% specific to AceView. In contrast, due to a
lack of large scale protein sequence evidence, we have
chosen different strategies to annotate the proteins:
Gencode proteins (of which 31% are partial) are annotated in
only 41% of the transcripts. It does not necessarily mean that
HAVANA predicts that the remaining 59% transcripts are
non-coding, but this is definitely what the Guigo et al.
analysis [6] assumed, and this biased their CDS analysis.
AceView, like all other methods except Gencode, conser-
vatively chose to annotate the best predicted CDS in nearly
all transcripts. Notice also that the Gencode hand annotation
of transcripts is available at this high quality only in the
ENCODE regions: their annotation of chromosome 20, for
example, is far less comprehensive (Thierry-Mieg and
Thierry-Mieg, unpublished) [4,7]; it may be too time
consuming to annotate a whole chromosome manually at
this depth while the cDNA data are accumulating so fast. In
contrast, because AceView is automatically generated, it can
provide for the whole genome a regularly updated annota-
tion of the intron-exon structure of the genes and their alter-
native transcript variants that, as we show here, is of a
quality comparable to the manual Gencode annotation. If
deemed desirable, AceView mRNAs could easily be re-anno-
tated with parsimonious Gencode-like CDSs.
The excellent agreement in gene structure between Gencode
and AceView provides a cross validation of both annotations.
The cDNA-supported consensus transcriptome includes
close to five times more transcripts than RefSeq, and three
times more than UCSC ‘Known Genes’, a track summarizing
the human protein-coding quality-filtered data from RefSeq,
GenBank mRNAs, and UniProt.
Results and discussion
Comparison of gene models using the
UCSCtrackCompare program
To compare the performance of all programs at reproducing
the rich Gencode annotation, we wrote a standalone
program, UCSCtrackCompare, available in source form in
Additional data file 1. The program compares, in chosen
genomic regions, a UCSC track or a collection of tracks taken
as reference (usually Gencode) against any number of
selected tracks. It produces, in about 10 minutes, support for
the analysis presented here; for a more detailed comparison
of transcripts see Additional data file 2 and for coding
regions see Additional data file 3. The direct outputs of
UCSCtrackCompare were pasted in an Excel document
(Additional data file 4). For the analyses of coding regions
comparable to [6], our results almost exactly match those
obtained by Guigo et al., and our results lie within 0.2% of
theirs (Tables 4 and 5 in [6]). However, there are uneven
discrepancies that cannot be rationalized, but that may reach
up to 8% in sensitivity and 13% in specificity, between our
mRNA comparisons (Table 6 in [6]; see Additional data file
2.1). Methods that show an advantage in [6] include
Ensembl, Exogean and Pairagon, and methods that show a
disadvantage include AceView, ECgene, SGP2 and eight
others. Yet, the general ordering of the methods is consistent
across the two evaluations.
On 14 December 2005, we downloaded from UCSC all tracks
with gene models in the 31 ENCODE test regions (see
Additional data file 2.1). We selected for comparison to
Gencode (October 2005 freeze) 14 non-redundant EGASP
tracks released before the solutions, and 10 genome-wide
tracks, distinguished on all diagrams by addition of an
asterisk in front of the track name. Nine tracks, labeled P in
front of their names, predict protein-only models by using
ab initio methods, often integrating evolutionary sequence
conservation; all others also use, or only use, mRNA and/or
EST evidence. Statistics of the 25 tracks and hints on their
inputs are summarized in Table 1.
Since the UCSC files give directly the exons of all tracks in a
uniform chromosome-based coordinate system, the com-
parison of coordinates is straightforward and easy to dupli-
cate (Additional data file 1). The choices offered in our
program are either to decompose the models into their ele-
ments, exons, introns and nucleotides, or to consider them
in their entirety; and then either to count each element with
given genomic coordinates only once, thereby providing a
rationalized projected measure of the unique elements (as
was done in [6]), or to count each element as many times as
it occurs in the alternative variants, providing a quantitative
appraisal of the biological complexity of the gene. The two
measures are complementary. Another option is to compare
only the part of the models annotated as protein-coding.
When applied to identical transcripts, this option allows the
preferred hypotheses on choice of CDS and Start codon to be
reverse engineered (Additional data file 2.5).
Comparison of introns, exons and nucleotides in
whole models
Consistently, when we compare whole mRNA models (rather
than CDSs) to the Gencode reference, AceView fares
remarkably well, better than any other track. This is true in
the projected mode, and even more striking in the quanti-
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htative mode, where alternative variants are counted separately
(see details in Additional data files 2 and 4).
Nucleotides provide a global appraisal of the transcribed
regions: AceView and Gencode spliced transcripts cover
almost exactly the same nucleotides in the genome (92%
sensitivity, 88% specificity; Additional data file 2.2). The
structural precision of the models is best defined by the
exact position of intron-exon boundaries. As shown in
Figure 1a, most of the unique Gencode introns are used in
AceView and few are added (sensitivity 90%, specificity
86%). Only AceView and ECgene (86.5%) detect more than
70% of the introns: the other EGASP tracks probably do not
succeed in aligning with sufficient precision all the available
ESTs and mRNAs. For reference, on 14 December 2005,
RefSeq sees 56% of the Gencode validated introns and the
S12.4 Genome Biology 2006, Volume 7, Supplement 1, Article S12 Thierry-Mieg and Thierry-Mieg http://genomebiology.com/2006/7/S1/S12
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Table 1
Statistics of the 25 selected tracks, arranged in the order of the UCSC genome browser
Model with  Single exon  Unique 
Model with  introns  model  introns in  All introns  Input or 
UCSC track introns and CDS (some clipped) mRNA in mRNA method
HAVANA Gencode (Sanger, UK)  1,691 649 70 3,618 9,693 MEP,CA,H
known + putative 
EGASP model submissions
AceView (NCBI, US) 1,630 1,460 24 3,530 9,597 ME,(H)
UP Dogfish (Sanger, UK) 204 204 15 1,679 1,679 CA
Exogean (ENS, France) 554 538 2 2,855 6,178 MEP,CA
UP ExonHunter (U Waterloo, Canada) 807 807 220 3,237 3,237 MEP,CA
Fgenesh (U London, UK) 462 458 97 2,610 3,241 P,CA
UP GeneId (IMIM, Spain) 267 267 51 1,905 1,905 A
UP GeneMark (Georgia IT, US) 551 551 81 2,185 2,185 A
UP Jigsaw (TIGR, US) 259 259 67 2,168 2,168 MEP,CA
PairagonAny (Wash U, US) 471 437 38 2,300 3,470 MEP?,CA
UP SGP2 (IMIM, Spain) 552 552 159 2,645 2,645 P,CA
P Twinscan-MARS (Wash U,US) 547 547 108 2,501 4,943 CA
UP Augustus Any (U Göttingen, Germany) 312 316 87 2,291 2,291 MEP,CA
UP GeneZilla (TIGR, US) 477 477 179 2,758 2,758 A
UP Saga (UC Berkeley, US) 331 331 47 1,737 1,737 CA
UCSC gene tracks
*Known Gene (UCSC) 501 477 53 2,264 4,427 MP
*P CCDS  201 201 14 1,296 1,508 MP,H
*RefSeq (NCBI, US) 342 325 41 2,082 2,922 M(E)P,H
*MGC 323 310 19 1,400 2,101 M
*Ensembl (EBI, UK) 427 418 58 2,429 3,548 MEP,CA
*AceView (Aug 2005 NCBI) 1,792 1,627 902 3,812 9,792 ME, (H)
*ECgene (Korea) 3,851 3,551 2,569 3,942 30,660 ME,C
*U NscanEst (Wash U, US) 282 252 27 2,292 2,292 ME,CA
*UP GenScan (MIT, US) 395 395 59 3,042 3,042 A
The number of models, with or without introns (after clipping at region boundaries), the number of spliced coding models, and the number of unique and
multiply used introns are given over the 31 ENCODE test regions. Coded information has been added in front of the track name: asterisks distinguish
standard gene tracks, available genome-wide, from an ENCODE only track; a U track predicts a unique model per gene; P predicts protein coding
regions only. According to their documentation, the programs use different input or methods: M, E, P stand for human mRNA, EST, protein sequences
or alignments, respectively; C stands for for conservation, or use of cDNA or protein evidence from other species; A stands for ab initio prediction; H
stands for Hand curation; and parenthesized letters stand for minimal use of the particular type. Notice the low proportion of Gencode mRNA models
with an annotated CDS (in bold).Mammalian Gene Collection (MGC) 38%. As expected, the
tracks relying mostly on ab initio predictions detect less
Gencode introns, but more novel intron candidates, usually
unique to each program (Additional data file 2.4);
ExonHunter and Genscan are the most creative.
If all introns from alternative variants are counted separately
(Figure 1b), Gencode uses close to three times the number of
unique introns. AceView does too, but remarkably in this
expansion, most of the introns remain exactly the same as in
Gencode (sensitivity 85%, specificity 84%). In contrast, the
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Figure 1
Comparison of introns between the Gencode reference and the 24 tracks, ordered by decreasing sensitivity, over the 31 test regions. Gencode validates
3,618 unique introns and a total of 9,693 introns in its alternative transcripts. (a) Projected measure: each intron is counted only once per method.
Introns with the same coordinates as Gencode introns are shown in green and novel introns in red. The Gencode introns missed in each track (false
negative) correspond to the distance between the ‘true positive’ bar and the Gencode reference, but are not explicitly represented. (b) Quantitative
measure: all alternative variants are counted separately. Introns identical to Gencode introns, but over-used relative to Gencode are counted (in yellow)
separately from novel introns that are not known to Gencode.
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(b)specificity of ECgene drops to 28%, because of their drastic
combinatorial use of the Gencode introns. This over-use
feature is apparent to a lesser extent in the ExonWalk track,
possibly because of excessive use of partial cDNAs in their
step 3 (for documentation, see [3]).
The comparison of exons (Additional data file 2.3) can also
assess the intron-exon boundaries of the models, but it is
dominated by the effects of terminal exons, which represent
20% to 42% of all exons (depending on the method), and are
often partial in transcript models. Furthermore, in contrast
to intron boundaries, which are accurate and can in
principle be verified by PCR or microarray experiments, the
boundaries of terminal exons cannot be defined precisely
even in a truly complete transcript because, biologically, the
first (capped) base and the polyA addition site fluctuate in
vivo [8] (D Thierry-Mieg and J Thierry-Mieg unpublished
observations). Indeed, when we compare exons between
Gencode and any other track, both sensitivity and specificity
drop because of the terminal exons (Additional data file 2.3).
Another advantage of comparing spliced models through
introns is that methods that predict only coding regions
(labeled P(name) in all figures and tables) are less disad-
vantaged in intron than in exon mode, because most introns
are located in the coding regions. This is true for example for
92% (2,075/2,264) of the unique introns in the UCSC
‘Known Gene’ track. We therefore chose to perform intron-
based comparisons of whole spliced transcripts. Single exon
genes and transcripts will be discussed separately below.
N to N comparison of entire mRNAs across methods
proposing alternative transcript models
On average, Gencode genes with introns have 4.5 transcripts
per gene; each transcript has 5.7 introns, but in projection
only contributes 2.1 unique introns. If we limit this to coding
transcripts, coding genes have on average 2.6 annotated
CDSs, and each CDS has 8 introns, but in projection only
contributes 3.7 unique introns (Additional data file 4,
SummaryStats). Just a few of the possible combinations of
introns correspond to supported models: this is called the
combinatorial splicing problem. To properly compare
performance across the tracks, we need to evaluate how the
introns and exons are chained in the models. Let us consider
each model as a non-separable chain of introns, the set of
coordinates of its intron boundaries on the genome provides
a precise signature. As illustrated in Figure 2a, we define the
one-to-one best matching Gencode-to-track-X model pair by
comparing all pairs and scoring intron boundaries: each
boundary counts +1 if it is shared by the two models or -1 if it
is unique to either of the two. In this way, identical models
always score best. All pairs of models with one intron
boundary in common are listed and sorted, and the two
models from the best rating pair are flagged as ‘best match’,
irrespective of their score. We then look recursively for the
next best rating pair where none of the two models are
flagged, and flag them. The remaining unflagged models in
the list become ‘additional variants in Gencode genes’.
Finally, the models that do not occur in the list are orphans
and belong to new genes, specific of method X, or to missed
genes, present only in the Gencode reference. Some of the
‘best matches’ are actually ‘identical to Gencode’ in terms of
intron-exon structure.
Figure 2b shows the results of this analysis (see also
Additional data file 4, complete models). More than 70% of
the Gencode transcripts have an exact structural equivalent
in AceView, from the first to the last intron (1,191/1,691 =
70% sensitivity, 67% specificity); an additional 12% (206)
have a best match. AceView misses 210 of the Gencode
variants but sees 225 new variants in other Gencode genes.
Finally, AceView misses some Gencode genes containing a
total of 88 transcripts with introns, but sees some genes
missed by Gencode, containing 170 transcripts with introns.
The second most sensitive track is ECgene (60% sensitivity;
26% specificity), which has twice as many spliced models as
Gencode to choose from, but has fewer identical transcripts
than AceView. The next best, ExonWalk and ‘Known Genes’,
drop sharply to 23% exact matches. RefSeq sees only 17% of
the Gencode transcripts and covers 53% of the unique
nucleotides and 56% of the unique introns: despite its well
recognized quality, RefSeq does not provide a comprehen-
sive representation of the transcriptome.
Intronless transcripts
By definition, the above analysis only evaluated transcripts
with introns. Transcripts and genes without introns are in
fact rare in the Gencode annotation (2.3% of the models,
plus 1.7% due to clipping at the boundaries of the ENCODE
regions). To better mimic Gencode, most were filtered by the
EGASP participants, including AceView, which normally
annotates a large number of single exon genes (Table 1;
Additional data file 4).
Although rare on the entire UCSC browser, unspliced
transcripts appear to be an important part of the human
transcriptome, and they are an order of magnitude more
frequent in mammals than in simpler Metazoa. Indeed, we
compared the high quality full-length cDNA libraries made
by Sugano using the oligo-capping method in either the
nematode Caenorhabditis elegans or human (all sequences
are in GenBank [7,9]). We removed 1.1% of clones that may
be genomic contaminants (331/29,562 aligned in an intron-
less gene ending on an A-rich region in the genome) and
found that the percentage of fully sequenced intronless
clones is 10 times greater in human than in worm (36% in
human (10,578/29,562 FLJ clones) versus 3.5% in worm
(2,010/56,671 worm yk capped clones)). These clones also
map in 11 times more unspliced genes (with no spliced
variants) in human than in worm (25% of these FLJ-
containing genes in human (4,261/17,214 genes) versus 2%
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immature transcripts (unspliced, but from a gene with
introns) is similar in the libraries from both species (57%
(6,043/10,578) in human, 59% (1,187/2,010) in the worm).
According to our analysis, the huge increase in intronless
genes is a major difference between the worm and human
transcriptomes. It may have co-evolved with the increased
usage of alternative splicing, increased intron length or other
transcriptional features. An intronless transcript is not
associated with an exon junction complex, so it is expected
to be translated and degraded less efficiently in human
[10-12], and it might be submitted to less evolutionary
pressure: unspliced genes could be where new functions
arise. Indeed, some of the unspliced genes potentially
encode small proteins (18,385 intronless genes have
hypothetical CDS of more than 100 amino acids; note that
most are human or mammal specific), some may be
regulatory non-coding RNAs, and some may just be trans-
cription by-products. We do annotate these genes in the
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Figure 2
Comparison of whole transcripts. (a) Strategy for selecting the best one to one matching pairs. (b) Comparison of whole transcripts through their
intron signatures. The number of transcripts identical to Gencode, best-matching but different from Gencode, new transcripts in Gencode genes and
new transcripts in new genes are represented.
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(b)public AceView [7] and expect that in the future the role of
intronless genes will be better apprehended.
Are Gencode mRNAs fully validated and complete?
We compared the introns of Gencode to those of other tracks
(Additional data file 2.4); 189 unique projected introns (5%
of their 3,618) are seen exclusively in the Gencode trans-
cripts but in no other track. We expect those to be supported
by Gencode experimental validation, although the evidence
was not submitted to GenBank as of August 2005. Another
possibility is that some might be supported only by
homology to non-human transcripts, as described in the
standard HAVANA procedure [4], in which case we hope
they are not exported to UniProt. Conversely, 681 ‘consen-
sual’ introns are seen by three tracks or more, or 340 are
seen by the strictly cDNA-supported AceView that are not
seen by Gencode. Actually, Gencode sees 8% of the consen-
sual introns missed by AceView, but AceView sees 72% of the
consensual introns missed by Gencode.
Overall, we find that the Gencode transcript annotation is
quite comprehensive except for the quasi-absence of
intronless genes. We confirm its high quality: it missed or
annotated as pseudogene only a few expressed genes seen by
AceView, and it did not exploit in the order of 15% of the
introns represented in cDNAs from the public databases.
In general, we especially appreciate the fact that they report
all observed transcripts with good alignments and standard
introns, without filtering those that are structurally candi-
dates for nonsense mediated RNA decay (NMD) [12]. Accor-
ding to our estimates [7], putative nonsense transcripts
represent about 13% of the fully supported transcripts with
predicted proteins of more than 100 amino acids in human
(12,855 of 101,877 have introns larger than 60 base-pairs
(bp) and with standard boundaries lying at least 55 bp
downstream of the Stop codon), in contrast to 4% in worm
(671 of 15,119 using the same criteria as above, except that
minimal intron size is 30 bp). This increase may parallel the
evolution of NMD into an essential multifunctional
mechanism in mammals [10-12], or it may indicate that our
cells have a more tolerant life style than the worm. Over the
past few years, evidence that mRNA may be functionally
active beyond its protein coding ability has accumulated
[13]; human transcripts have a complex life, with mecha-
nisms present to protect the mRNA, modulate its accessi-
bility to the ribosome or to specific modification or proces-
sing enzymes, monitor its aging, its position in the cell, or its
stability [10]. A comprehensive uninterpreted catalog of
observed transcripts is needed to help understand all this
complexity, and Gencode or AceView aim at this goal.
Selecting protein coding transcripts and regions can
only be an educated guess
A glimpse at the ENCODE regions of the UCSC genome
browser [3] shows that Gencode and AceView transcripts
look quite different from the other tracks, but so similar to
one another that it would be hard to guess which is which if
the names of the tracks were masked. However, Guigo and
Reese [5] state that there is no clear winner at finding the
Gencode coding regions. These two observations are in fact
not contradictory: annotation of transcripts is based on large
amounts of experimental cDNA evidence, so Gencode and
AceView can agree almost perfectly. In contrast, we diverge
on protein annotation, because there is almost no experi-
mental protein sequence data available today. For this
reason, most protein annotation remains hypothetical. Even
proteins from UniProt/SwissProt are now contaminated by
CDS predictions derived from transcriptome annotation,
which makes new predictions by homology more and more
circular. For instance, UniProt currently harbors 23,298
C. elegans proteins, but one should be aware that those are
predictions: at most, 9,487 have complete cDNA support,
and almost none has been sequenced. Until a substantial
amount of direct protein sequences is generated, it is not
surprising that different points of view coexist. For instance,
Gencode annotates a CDS in only 41% of their transcripts,
whereas all other tracks, including AceView, conventionally
annotate a CDS in almost all their transcripts. Precisely
because Gencode and AceView transcripts are so similar, the
apparent specificity of AceView automatically drops by 59%
when we compare CDSs, and the resemblance between the
two methods is no longer striking (Additional data file 3, in
agreement with [6] for the projected view).
In this context, AceView considers the CDS problem fully
open, and offers no guarantee on which actual proteins are
made [7]. In practice, we identify all possible CDSs, usually
more than one per transcript, and annotate those larger than
50 amino acids using BlastP, PFAM, and Psort2. All hypo-
thetical CDSs are available from our download page to help
identify mass spectra. But to simplify the display, we pick a
single ‘best product’ per transcript, knowing it may not
reflect the situation in vivo, since it does not follow closely
the rules indicated by Kozak [14]. For example, we do not
necessarily choose the first CDS, which is quite often a short
upstream open reading frame (uORF) [15,16], and we do not
reinitiate and display multiple products per transcript. The
‘best’ protein is defined by considering, in a graded fashion,
the presence of a Pfam protein domain, BlastP homologies,
TaxBlast conservation, specific Psort annotations, maximi-
zation of introns within the CDS, position along the
transcript and size of the CDS. If the mRNA is not known to
be complete (if its 5’ end is not defined by a capped clone)
and the frame is open on the 5’ side, the AceView CDS starts
at the first in frame codon. But if the mRNA appears to be
complete, the CDS starts at the first AUG codon, unless there
is, in the correct environment, an in frame NUG or ANG
codon [14,17-20] at least 180 bp upstream of the first AUG.
In such a case, we annotate a predicted CDS starting at the
non-AUG codon (the limit was set at 60 bp in the August
2005 release, leading to an excessive 24% complete CDS
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to use about 17% non-AUG start, and to our surprise 7% of
the human best complete products in AceView (20,616 of
293,158) actually have an alternative Start codon in the
correct environment 60 amino acids upstream of the first
AUG. It will be interesting to see how many are occasionally
used as Start in vivo.
On the other hand, Gencode departs from all other programs
in that it does not call a CDS unless it is conserved or already
annotated in SwissProt, and it has a ‘sensible’ gene structure
that is not a candidate for NMD. The product they annotate
is almost always the same as AceView, except that the Start
codon may differ. In reality, they probably do not really
mean that 59% of the transcripts from protein coding genes
are non-coding, but they just have to be very careful, because
their proteins are poured directly in the UniProt reference
database, so any annotation error will spread. We respect
their attitude, yet some of their choices can be questioned.
NMD transcripts for instance are expected to produce,
briefly but efficiently, truncated proteins, some of which
could be functional [12]. Indeed, activation of mRNA degra-
dation by this pathway requires a pioneering round of trans-
lation that, due to the dual role of NMD proteins in
activating translation, should be very efficient on transcripts
still decorated with exon junction complexes (reviewed in
[10,11]). Furthermore, NMD is only shortening transcripts
lifetime by 1.5 to 11 times [21], and it remains possible that it
does not act in all cells and tissues at all times. The leaky
behavior of the surveillance machinery is well known to
geneticists: if no protein was produced from NMD candi-
dates, the great majority of nonsense mutations would
behave as complete loss of function (true nulls), but there
are a number of counter-examples where a well positioned
stop mutation leads to a gain of function phenotype (for
example, lin-1 allele n1790 [22]).
With respect to the choice of the initiation codon, Gencode
and other groups give much weight to interspecies conser-
vation, they do not annotate upstream ORFs, and consider
only AUG codons. But it is difficult to conceive how the
ribosomes would be aware of these rules, instead of follow-
ing the scanning mechanism experimentally established by
Kozak [14]. If the transcript is accessible, upon scanning, the
ribosome subunits assemble at the first AUG (or more rarely
at an alternative start), irrespective of the length and inter-
species conservation of the protein. If there is a stop codon
soon after the AUG, the ribosome will keep scanning rather
than drop off, and may reinitiate synthesis of a second
product.
In summary, protein annotation is not supported by enough
direct protein sequence evidence, and large scale mass
spectrometry data on proteins are badly needed to clarify
what happens in vivo.
Validating the transcriptome through democratic
consensus
Annotating the transcriptome is a difficult and dynamic task,
the data and the rules do evolve, and even the most careful
manual annotation cannot be expected to provide by itself
an incontestable and final truth. There are strengths and
weaknesses in each annotation, but good mRNA models
supported by strong cDNA data should be found by more
than one method. Therefore, an alternative way to select a
benchmark may be to take a democratic approach: instead of
considering a single track as ‘reference’, we propose to pool
independent cDNA-supported annotations and search for
consensual models.
A caveat is that some annotations, such as RefSeq, CCDS or
UniProt/SwissProt, are so renowned that most methods use
them as a data source in addition to the primary cDNA or
protein data, so these models are sticky and will end up
validated, whether or not they are correct. Manual annota-
tion is invariably the source of second-hand annotation
problems. In fact, in AceView, we do not use SwissProt for
this reason, and we now explicitly label all transcripts whose
structure is supported only by a RefSeq model as possibly
suspect. In the same vein, we use only human cDNAs at the
exclusion of any other species, even mammals or primates.
We implemented the democratic idea in two flavors in
UCSCtrackCompare: we either rotate the reference from
Gencode to any other track and perform a closest neighbor
consensus analysis (Figure 3b); or, alternatively, we pick as
reference a selected pool of tracks and the program extracts
their consensual models (for instance those whose intron
structure is identical in at least two independent annotation
tracks) and measures, for each of the 25 tracks, the number
of models exactly matched, hence their sensitivity and
specificity.
Table 2 and Figure 3a show the results of the pooling analysis,
where the consensual set are the 1,556 spliced transcripts
seen by at least 2 of the 7 evidence-based independent
methods: Gencode, UCSC Known Genes, RefSeq, Ensembl,
AceView, ECgene and ExonWalk. AceView and Gencode fare
best, with 84% and 81% sensitivity and 73% and 74%
specificity, respectively. The next most sensitive method is
ECgene, with 77% confirmed models, but its specificity is
only 31%. ExonWalk, UCSC Known Genes, and Exogean
provide considerably fewer models (33% to 26% sensitivity).
ExonWalk and its closest neighbor ECgene suffer from low
specificity, unless both are included in the reference set,
probably because they allow combinatorial arrangements of
the introns. It would be interesting to know how frequently
these entire models are validated in RT-PCR experiments.
Then come in order RefSeq, Pairagon, Ensembl, MGC,
Fgenesh, and CCDS. Finally, the 12 remaining methods are
less sensitive than CCDS, as shown in Figure 3a. This
analysis is robust against variations in the composition of
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hthe reference set, as long as both Gencode and AceView or
ECgene are included. It is even stable if we include the 23
unrelated tracks in the reference pool, yielding 1,957
consensual models (Additional data file 2.6). But if AceView
and ECgene are excluded, the consensus falls down to only
478 transcripts across NCBI RefSeq, UCSC Known Gene,
EBI Ensembl and Sanger Institute Gencode. In this context,
Gencode has an appalling specificity of only 26%. Fortu-
nately, its agreement with AceView cross-validates both
methods.
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Figure 3
Consensus analysis. (a) Sensitivity and specificity at identifying 1,556 consensus transcripts from the pool of the following evidence-based tracks: RefSeq,
Known Gene, Ensembl, Gencode, AceView, ECgene and ExonWalk. The sensitivity and specificity of all tracks at identifying these consensus models is
plotted and listed in Table 2. (b) Closest neighbor consensus, evaluated by switching the track of reference. This figure shows the number of evidence-
based models from CCDS, RefSeq, UCSC Known Genes, Gencode, or AceView, ExonWalk and Ensembl whose intron-exon structure is exactly
matched by the 25 tracks. Tracks are arranged in decreasing order of averaged detection sensitivity, defined here as the sum of all evidence-based
models from these seven reference tracks detected exactly.
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(a)
(b)Another view is shown in Figure 3b, which displays the
closest neighbor consensus analysis (see also Additional data
files 2.6 and 3.1 and 3.6). The sum over seven references of
the number of exactly matching models was used to order
the tracks. Interestingly, all tracks spontaneously appear to
be ordered in overall sensitivity, almost independently of the
chosen reference. Gencode and AceView are nearly indistin-
guishable. With 1,191 models in common, they are by far the
most sensitive, but retain a very good specificity. In a robust
way, they detect the largest number of models from all other
tracks; they are the most inclusive, and three times more
thorough than any other reference track (see Additional data
file 2.6).
To our surprise, Ensembl, which is often used as a reference
catalog, in particular to count the human genes [23], is not
consensual, and far below Gencode and AceView in both
sensitivity and specificity. While it offers more models than
RefSeq (427 versus 342), fewer are confirmed by at least one
other method (270 versus 304 in the closest neighbor
analysis, 295 versus 332 in the democratic consensus), but
the caveat about the artificial increase of specificity and
sensitivity of RefSeq certainly applies here. However, the
quality of the RefSeq is truly higher than suggested by
ExonWalk, Ensembl or Exogean, which validate only 220 to
224 of the 342 RefSeqs: in the EGASP AceView version, we
purposely did not use the RefSeqs as a source, yet we
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Table 2
Sensitivity and specificity of each method at detecting the 1,556 consensus transcripts
Number of models  Consensual models 
Track with introns (of 1,556 total) Sensitivity Specificity
*AceView 1,792 1,302 84% 73%
Gencode 1,691 1,255 81% 74%
*ECgene 3,851 1,198 77% 31%
AceView 1,630 1,165 75% 71%
*ExonWalk 892 511 33% 57%
*Known Gene 501 432 28% 86%
Exogean 554 404 26% 73%
*RefSeq 342 332 21% 97%
Pairagon 471 310 20% 66%
*Ensembl 427 295 19% 69%
*MGC 323 217 14% 67%
Fgenesh 462 217 14% 47%
*P CCDS 201 152 10% 76%
UP Jigsaw 259 150 10% 58%
*U NscanEst 282 104 7% 37%
UP Augustus 312 100 6% 32%
P Twinscan 547 77 5% 14%
UP GeneMark 551 50 3% 9%
UP SGP2 552 48 3% 9%
UP GeneZilla 477 47 3% 10%
UP ExonHunter 807 41 3% 5%
UP GeneID 267 38 2% 14%
*UP GenScan 395 37 2% 9%
UP Dogfish 204 33 2% 16%
UP Saga 331 18 1% 5%
Sensitivity and specificity of each method at detecting the 1,556 consensus transcripts across the pool of the following evidence based tracks: RefSeq,
Known Gene, Ensembl, Gencode, AceView, ECgene and ExonWalk, as in Figure 3a. Coded information has been added in front of the track name:
asterisks distinguish standard gene tracks, available genome-wide, from an ENCODE only track; a U track predicts a unique model per gene; P predicts
protein coding regions only.confirmed the intron-exon structure of 82% of them (279).
However, RefSeq is far from comprehensive. The even smaller
CCDS collection is equally well matched by many tracks, but
at the protein level (Additional data file 3.6), they are
perfectly matched only by Ensembl (201), and not quite by
the other members of the CCDS collaboration: RefSeq (197),
Gencode (182) and UCSC (189). It is definitely difficult to
agree on any standard for protein annotation.
AceView summarizes GenBank and dbEST into a
comprehensive evidence-based gene annotation by
performing hand-supervised automatic annotation
The fact that the manually curated Gencode and automatic
AceView transcripts are so similar shows that the critical
information for the intron-exon structure of a Gencode-like
validated annotation is almost entirely contained in the
combination of human ESTs, mRNAs and the genome. It
appears that AceView is now able to automatically extract
this information, with little more noise than a team of
careful human experts. The resemblance also indicates that
we have the same, possibly biased, way of looking at the data
and that we apply similar filters when annotating transcripts.
To reconstruct the genes, AceView considers all cDNA
sequences submitted to the public databases, and stringently
co-aligns them at their single best position on the genome
[7]. Its cDNA to genome alignment algorithms are finely
tuned to clip vectors and poly-A and to filter away 3% of the
cDNAs because of insufficient quality of their best alignment
(especially if they map in multiple genomic locations), and
2.2% because of suspected structural defects; 3.7% of the
cDNAs are strand-inverted. The alignments are seeded on
exact matches of 15 bp and extended using a finite automa-
ton able to switch from normal to insertion or deletion mode
when the EST fasta file starts calling bases at the wrong
frequency. Missing exons are researched aggressively, seeding
on 6 bp words. Short hits are counted not in base-pairs but
in entropy, assuming that each base is statistically indepen-
dent from its neighbors. This is an over-simplification, but
the advantage is that, for instance, an AT rich region is
penalized and at the extreme a pure poly-A hit counts zero.
The intron-exon boundaries are then refined by co-
alignment. Finally, we reject the very long introns unless
they are bounded by strong exon support. Aligned cDNAs
are then clustered into the minimal set of transcripts (that is,
a gene) consistent with their complete intron-exon structure.
Most of the gene models with multiple cDNAs have alter-
native variants, but since September 2004, in order to limit
combinatorial expansion of variants, we minimize
concatenation by using each cDNA in one and only one
transcript, favoring a silent merge in a known compatible
transcript, so that only cDNAs containing a specific alter-
native feature are singled out. As a result, some variants are
partial, but 70% of all AceView transcripts have their
predicted CDS entirely supported by a single identified
cDNA. The remaining models require concatenation of rarer
forms, and will possibly be split into multiple alternative
variants when additional data become available.
We then name the gene by physical contact to an NCBI
Entrez gene model, else by alignment of a RefSeq or
GenBank mRNA assigned to an Entrez gene, else by a Pfam-
containing name, else by a nickname. The nickname is a
number encoded in decodable pseudo English or pseudo
Japanese by using a set of phonemes as basic digits. All
names and previous aliases are tracked from release to
release, and de facto AceView closely follows the official
HUGO and Entrez gene nomenclature.
However, genome annotation cannot be fully automatic. We
must often look at the genes, and take significant decisions
to resolve the irregularities. The difficulty is to maintain this
hand annotation over the years, as new data become available.
For example, the hand annotations of the first Drosophila
jamboree and of the initial version of the Celera human
genome were nearly entirely lost. In AceView, we have
limited manpower, just the two of us, so we had to devise an
efficient cumulative methodology. Rather than hand anno-
tating the final report of a gene, we only provide hints that
are incorporated automatically in the context of the most
recent data. For example, if the program seems to merge two
genes in an unreasonable way, we do not create a permanent
wall between them; instead, we hand annotate a few cDNA
clones as having a ‘real 3’ end’ or ‘real 5’ end’, and then port
these annotations from build to build. These hints will
probably induce the program to split the gene, but if
tomorrow a new mRNA sequence strongly bridges the two
genes, they will automatically be reunified. When a significant
number of genes need the same kind of manual hints, we
add a piece of code that performs the same task and then
drop the manual annotations once they are automatically
reproduced, and even often enhanced. For example, at the
EGASP meeting, we learnt that non-standard introns
(neither GT/AG, nor GC/AG) are not usually validated by
RT-PCR: we now discard any cDNA variant with a non-
standard intron, unless it also brings a novel alternative
intron with standard boundaries. As a result, we reduce the
noise, but if many clones in a gene use a particular non-
standard intron boundary, for instance because of an error
in the genome sequence or because the intron is truly non-
standard, this intron will naturally sift through our tolerant
rule and be kept in AceView.
AceView is a service to the community, it does not provide a
final answer, but rather some rated proposals aimed at
stimulating confirmatory experiments. By using the genome
as a guide, it automatically rectifies the sequencing errors in
the cDNAs and brings these sequences in line with the
excellent quality of the genome itself. But it only provides a
partial view of the entire transcriptome, because we are still
far from saturation in cDNAs. From release to release, we
improve the models by incorporating the latest cDNA data,
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redefined the gene as a set of transcripts sharing at least one
intron boundary, instead of a simple sequence contact. This
disentangled the numerous contiguous genes with 3’ 5’ un-
translated region (UTR) overlap and separated the unspliced
variants, improving the gene annotation in directions wished
for by the users.
Because Gencode annotation is manual, it may prove more
difficult for them to include new data or to implement a
change in strategy. For example, one can read on the
HAVANA guideline site: “Occasionally a short two exon
product is supported by Fgenesh and Genscan, in which case
the object can be translated. It is then annotated as
“believable CDS”.” This rule was recently abandoned, but it
will be labor-intensive to hand revise all previous models
accordingly.
The puzzle of gene counts
Gencode annotates 3,618 distinct introns. But this is
possibly only the tip of the iceberg, since 10,241 other
introns in coding regions are predicted in EGASP, mostly by
ab initio methods. If a proportion of those were correct, we
might have mRNA or EST support for maybe only half of the
introns and, by extension, we might be missing an
appreciable fraction of the genes.
The parallel with the nematode C. elegans is interesting. In
“So many genes, such a little worm” [24], Hillier et al. count
19,735 coding genes in WormBase. But when we analyze all
available cDNA sequences in AceView WormGenes [7], we
find only 16,094 worm genes with direct experimental
evidence, of which about 700 are not annotated in the current
WormBase (WS150). There are 12,083 genes supported by
cDNAs, mainly from the large scale libraries from Kohara
and collaborators (all sequences are in GenBank). An
additional 4,011 genes or gene fragments are supported only
by the systematic RT-PCR amplification of predicted ORFs
from the Vidal ORFeome project [25]. So we conclude that
the authors of [24] are confident that, in addition to the
cDNA supported genes and the 4,011 gene fragments
supported by RT-PCR amplification, close to 4,400 genes
that remain pure ab initio predictions really exist. Indeed,
they exported them to SwissProt/UniProt.
On the other hand, these authors and their collaborators
[23] claim that the human genome contains a maximum of
25,000 protein coding genes. They consider that nearly all of
them are already known, that the numerous cDNAs that map
outside of their official gene list possibly ‘reflect reproducible
transcriptional noise’, and they do not expect any reliable
gene to come from ab initio predictions. However, AceView
unambiguously reconstructs from the readily available
human cDNAs about 40,000 genes potentially encoding
more than 100 amino acids (22,280 spliced and 18,385
intronless in the August 2005 version), in addition to 13,133
spliced genes encoding shorter proteins or non-coding.
Moreover, as we see in EGASP, many ab initio predictions
can be proposed in between cDNA supported genes and,
unlike in the worm, no intense RT-PCR experiments have
yet been launched in human. Preliminary EGASP results [6]
only provide a lower bound on their existence, because only
a fraction of the cDNA supported introns of Gencode and
AceView have been validated and ab initio predictions are
expected to be less expressed. If we apply a uniform method
to count genes, we are forced to conclude that human has at
least 3 times as many coding genes as the worm, and at least
10 times as many protein isoforms.
Conclusions
EGASP [5,6] and the availability of the excellent Gencode/
HAVANA models have helped us to significantly refine the
AceView pipeline. The structure of the AceView transcripts is
extremely similar to the Gencode benchmark, so AceView
appears to provide today the most comprehensive and
accurate representation of the entire human transcriptome.
On the other hand, due to a profound lack of experimental
protein evidence, annotation of coding sequences remains
controversial. We hope that this situation will rapidly
improve with the current progress of mass spectrometry and
a new understanding of the complex regulation of the trans-
lation machinery in vertebrates.
There are currently at least three times more protein coding
genes in human than in worm, but the human transcriptome
is still far from saturation; 23% of the standard introns
observed today in Gencode or AceView are still only
supported by a single cDNA. Consistently, the number of
variants and alternative introns keeps increasing almost
linearly with new cDNA sequences: the addition to GenBank
in January 2006 of close to two million 5’ complete capped
ESTs by the Japanese FLJ group [26] proportionately
increased by 26% the number of alternative variants, and
added 7% new spliced genes to the AceView collection [7]. In
line with these observations, ab initio methods propose a
wide variety of new models, and suggest that we may
currently know only a fraction of the protein coding genes.
To learn more about the genes expressed at low level, we
depend on future technological improvements, in particular
in the microarray domain, and on the continued acquisition
of new data. We hope to integrate this flow of information
seamlessly in the AceView hand-supervised automatic
pipeline.
Materials and methods
The UCSCtrackCompare program used in this analysis can
be downloaded from the AceView web page [7] and can be
compiled on any properly configured Unix, Mac or Windows
machine. A few precompiled executables and the whole
source code are available. A description of the program and
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in the four Additional data files.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is the
UCSCtrackCompare package: a user’s guide. The
UCSCtrackCompare code is written in C. This document
explains how to use the code, which options can be specified,
and which results and analyses are generated. Additional
data file 2 provides analyses of the entire transcript models.
This document includes notes on the data and the selected
tracks, comparisons to the Guigo et al. tables [6], and a
series of diagrams showing comparisons, over the 25 tracks,
of nucleotides, exons, spliced transcripts and regions of the
transcripts annotated as coding. Both qualitative (projected
on the genome, each object counts only once) and
quantitative (multiple alternative variants contribute
separately) analyses are described graphically. Gencode is
evaluated, and results from a consensus analysis, depicting
the transcript agreement across all tracks, are presented.
Additional data file 3 provides analyses of the regions
annotated as protein-coding. This document is similar to
Additional data file 2, but the analysis is limited to the
regions annotated as CDS. When alternative variants are
considered separately, the resemblance between Gencode
and AceView remains apparent. But when all alternative
variants are collapsed, as done in [6], the amazing coherence
between Gencode and AceView is obscured. As shown in our
consensus analysis, this bias is due to the fact that Gencode
annotates proteins in only 41% of their mRNAs. Additional
data file 4 includes direct results of the UCSCtrackCompare
program arranged in seven excel sheets: Regions, Summary
stats, Nucleotides, Introns, Exons, Complete models
(includes comparisons to Gencode and to 14 other tracks
taken as reference), and Consensus analysis.
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